However, extracting individual fibrinogen variants from human donor plasma is ... offers significant advantages over plasma-derived topical haemostat products, a market worth $1.2 billion worldwide.

A recent study published in Engineering presents a novel approach to analyzing the low-abundant N-glycoproteome in human blood plasma (HBP), which could significantly advance the discovery of plasma ...

Oxfordshire blood donors are playing a part in the "landmark moment", which will reduce the UK's reliance on imported ...